Results 101 to 110 of about 306,084 (179)

Interferon alfa-2a in the treatment of Behçet's disease.

, 1996
Background: There is no definite treatment for Behcet's disease. New drugs are being evaluated in cases unresponsive to conventional treatment modalities.
Erkan, F, Kavala, M, Kural, Z, Azizlerli, G, Kayabali, M, Kose, A, Ovul, C, Sarica, Rıfkiye   +7 more
core   +1 more source

Interferon-alfa treatment of facial infantile haemangiomas

, 2001
ophthalmology, haemangiomas of the face, infancy, Interferon alfa, eye at risk, amblyopia, induced refractive change, ultrasound ...
Prause, J.U., Fledelius, Hans C., Jensen, H., Illum, N.   +3 more
core   +1 more source

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C

, 2001
This international, randomized, active-controlled, parallel-group, double-blind dose-finding study compared peginterferon alfa-2b (PegIntron™) to interferon alfa-2b for the initial treatment of compensated chronic hepatitis C.
Goodman, Zachary D, Lindsay, Karen L, Schiff, Eugene R, Albrecht, Janice K, Hoefs, John C, Laughlin, Mark, Yao, Ruji, Heintges, Tobias, Trepo, Christian, Gordon, Stuart C, Shiffman, Mitchell L   +10 more
core   +1 more source

Tratamiento del linfoma cutáneo de células T con bexaroteno a dosis bajas en combinación con fototerapia o interferon alfa: comunicación de ocho casos tratados en el Hospital Edgardo Rebagliati Martins, 2003-2007, Lima, Perú

Acta Médica Peruana, 2018
Introducción: bexaroteno es un rexinoide aprobado en el tratamiento de estadios tempranos y avanzados del linfoma cutáneo de células T (LCCT). Caso Clínico: el presente reporte de casos mostramos los resultados del empleo de bexaroteno en dosis bajas ...
Brady Beltrán Gárate, Antonio Paredes Arcos, Celia Moisés Alfaro, Gadwin Sanchez Félix, Luis Riva Gonzales, Fernando Hurtado de Mendoza, Esther Cotrina Montenegro, Renzo Salas Rojas   +7 more
doaj  

RELATIONSHIP BETWEEN FIBROSIS SCORE AND RESPONSE TO INTERFERON ALFA & RIBAVIRIN COMBINATION THERAPY IN CHRONIC HCV INFECTION

Pakistan Armed Forces Medical Journal, 2009
Objective: To compare the response to Interferon Alfa (IFN) and Ribavirin (RBV) combination therapy in patients of chronic HCV infection with fibrosis stage 1 (F1) & stage 2 (F2) with fibrosis stage 3 (F3) & stage 4 (F4).
Nauman Kashif, Shahzad Saeed, Tariq Mahmood Ahmad   +2 more
doaj   +2 more sources

Kronik Hepatit C İnfeksiyonda Pegileinterferon Alfa 2A ve Ribavirin Kombinasyonu ile İnterferon Alfa 2A ve Ribavirin Kombinasyonunun Yan Etkilerinin Karşılaştırılması

, 2010
Objectives: Comparision of the side effects due to interferon alpha 2a plus ribavirin and pegylated interferon alpha 2a plus ribavirin combinations for chronic hepatitis C infection.
Ural, Onur, Aktuğ Demir, Nazlım, Balcı, Mehmet, Ural, Gaye, Sümer, Şua   +4 more
core   +1 more source

Efectividad del interferón peguilado alfa 2a más ribavirina para la hepatitis crónica C en la práctica

Acta Gastroenterológica Latinoamericana, 2010
Antecedentes. En la actualidad el tratamiento estándar y consensuado de la infección crónica por el virus de la hepatitis C se basa en la combinación de dos fármacos: interferón peguilado y ribavirina.
Nelia Hernández, Germán Mescia, Carmen Pollio, Gabriela Robaina, Laura Quintana, Carla Bianchi   +5 more
doaj  

Failure of interferon alfa and tribavirin in rabies encephalitis.

, 1989
OBJECTIVE: To test the effect of interferon alfa and tribavirin (ribavirin) in patients with rabies encephalitis. DESIGN: An open trial of chemotherapy and intensive care in patients with early rabies.
Looareesuwan, S, NICHOLSON, K, WHITE, N, VANNAPHAN, S, Chanthavanich, P, WARRELL, D, Nicholson, KG, Riganti, M, Manatsathit, S, FISHERHOCH, S, PHILLIPS, R, White, NJ, White, Nicholas, Suntharasamai, P, WARRELL, M, Phillips, RE, Warrell, MJ, Fisher-Hoch, SP   +17 more
core   +1 more source

Recombinant Interferon Alfa Therapy for Chronic Hepatitis C

, 1989
Infection with the hepatitis C virus may result in chronic liver disease for which no effective therapy is now available. We studied the effects of recombinant human interferon alfa in a prospective, randomized, double-blind, placebo-controlled trial in ...
Chris Kassianides, Murray, L, Kassianides, C, Linda Murray, Steven M. Banks, Goodman, Z, Jay H. Hoofnagle, Jeanne Waggoner, Di Bisceglie, A M, Mauricio Lisker-Melman, Adrian M. Di Bisceglie, Hoofnagle, J H, Zachary Goodman, Lisker-Melman, M, Paul Martin, Banks, S M, Waggoner, J, Martin, P   +17 more
core   +1 more source

Efficacy and safety of the type I interferon receptor inhibitor anifrolumab in patients with systemic lupus erythematosus (results of a 6-month study)

Современная ревматология
Objective: to evaluate the efficacy and safety of the type I interferon (IFN) receptor inhibitor anifrolumab (AFM, Safnelo®) in patients with systemic lupus erythematosus (SLE) in real-life clinical practice over an observation period of 6 months ...
T. M. Reshetnyak, E. A. Aseeva, A. A. Shumilova, N.  Yu. Nikishina, S. I. Glukhova, S. Yu. Shkireeva, A. M. Lila   +6 more
doaj   +1 more source